Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial

• Phillip Knebel,
• Markus W Büchler,
• Markus K Diener,
• Felix J Hüttner,
• André L Mihaljevic,
• Oliver Strobel,
• Gauthier Bouche,
• Johannes Hüsing

Affiliations

Phillip Knebel

Department of General, Visceral and Transplantation Surgery, Universitätsklinikum Heidelberg, Heidelberg, Germany

Markus W Büchler

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany

Markus K Diener

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany

Felix J Hüttner

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany

André L Mihaljevic

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany

Oliver Strobel

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany

Gauthier Bouche

The Anticancer Fund, Brussels, Belgium

Johannes Hüsing

Coordination Center for Clinical Trials, Heidelberg University, Heidelberg, Germany